Andere talen Oramed Pharmaceuticals Inc.

Aandelen

ORMP

US68403P2039

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,35 ^USD	+0,43%		-4,47%	+1,73%

19/03	Oramed Pharmaceuticals Inc. Benoemt Yehuda Reznick tot bestuurder, met ingang van 1 april 2024	CI
06/03	Oramed Pharmaceuticals Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01
Oramed Pharmaceuticals : Other Report or Announcement	24/12
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	19/12
Oramed: Q3 Earnings Snapshot	10/11
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Oramed Pharmaceuticals Inc.(TASE:ORMP) dropped from TA-125 Index	03/11
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	21-09-23
Scilex Holding Company announced that it has received $101.875 million in funding from Oramed Pharmaceuticals Inc.	21-09-23
Oramed Pharmaceuticals Inc. cancelled the acquisition of 40.17% stake in Scilex Holding Company from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q).	21-09-23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
Oramed Pharmaceuticals : Other Report or Announcement	07-08-23
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K	07-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Oramed Pharmaceuticals Inc.

Aandelen

ORMP

US68403P2039

Andere talen

Filters